Mckesson Corporation
MCK
Market Cap$72.16B
Close$
Earnings Call Q3 2024
February 7, 2024 - AI Summary
McKesson reported solid financial performance in the third quarter of fiscal 2024, with total revenues of $80.9 billion and adjusted earnings per diluted share of $7.74, both growing by double-digits compared to the prior year.
The company raised and narrowed its guidance range for fiscal 2024 adjusted earnings per diluted share from $26.80-$27.40 to an updated range of $27.25-$27.65.
McKesson's U.S. pharmaceutical segment showed strong momentum, with adjusted operating profit growing 6% and volume increases across customer channels, including specialty pharmaceuticals and GLP-1 medications.
Exclusive for Stockcircle Pro members
Sign up
$862.53
54% upside
Current Fair Value
54% upsideUndervalued by 54% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $72.16 Billion |
|---|---|
| Enterprise Value | $73.20 Billion |
| Dividend Yield | $2.3971 (0.43%) |
| Earnings per Share | $22.11 |
| Beta | -0.02 |
| Outstanding Shares | 129,985,514 |
| Avg 30 Day Volume | 744,146 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 24.07 |
|---|---|
| PEG | 4735.5 |
| Price to Sales | 0.24 |
| Price to Book Ratio | -34.99 |
| Enterprise Value to Revenue | 0.24 |
| Enterprise Value to EBIT | 17.53 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | -2.86 |
Revenue Sources
No data
ESG Score
No data
About Mckesson Corporation
80,000 employees
CEO: Brian Tyler McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, p...